Pelaris, Lorrie-mae B.

HRN: 20-75-97  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2022
AMPICILLIN 1GM (VIAL)
07/19/2022
07/26/2022
IV
2gms
Q6H
G1P0 40 Weeks AOG; PROM X 4 Hours
Waiting Final Action 
07/19/2022
CEFUROXIME 500MG (TAB)
07/19/2022
07/25/2022
ORAL
500mg
BID
RMLE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: